Skip to main content
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
7.94
-0.01 (-0.13%)
At close: Apr 28, 2026, 4:00 PM EDT
7.93
-0.01 (-0.13%)
After-hours: Apr 28, 2026, 7:12 PM EDT

ARS Pharmaceuticals Revenue

In the year 2025, ARS Pharmaceuticals had annual revenue of $84.28M, down -5.46%. ARS Pharmaceuticals had revenue of $28.09M in the quarter ending December 31, 2025, a decrease of -67.56%.

Revenue (ttm)
$84.28M
Revenue Growth
-5.46%
P/S Ratio
9.36
Revenue / Employee
$517,043
Employees
163
Market Cap
788.42M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202584.28M-4.87M-5.46%
Dec 31, 202489.15M89.12M297,063.33%
Dec 31, 202330.00K-1.29M-97.72%
Dec 31, 20221.32M-4.19M-76.10%
Dec 31, 20215.51M-12.33M-69.13%
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MannKind 348.97M
Theravance Biopharma 107.46M
MeiraGTx Holdings 81.39M
Kura Oncology 67.48M
Arbutus Biopharma 14.08M
Crescent Biopharma 10.84M
Allogene Therapeutics 22.00K
Revenue Rankings

SPRY News

More News